Literature DB >> 27867971

Another promise against ischemia reperfusion injury: every success raises new questions.

Dennis V Cokkinos1.   

Abstract

Entities:  

Year:  2016        PMID： 27867971      PMCID： PMC5104652          DOI： 10.21037/atm.2016.08.33

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  25 in total

Review 1.  MicroRNAs in cardiac apoptosis.

Authors:  Peifeng Li
Journal:  J Cardiovasc Transl Res       Date:  2010-03-19       Impact factor: 4.132

2.  Caspase-1 is a direct target gene of ETS1 and plays a role in ETS1-induced apoptosis.

Authors:  Huiping Pei; Chunyang Li; Yair Adereth; Tien Hsu; Dennis K Watson; Runzhao Li
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

3.  Plasma miR-208 as a biomarker of myocardial injury.

Authors:  Xu Ji; Rie Takahashi; Yumiko Hiura; Go Hirokawa; Yasue Fukushima; Naoharu Iwai
Journal:  Clin Chem       Date:  2009-08-20       Impact factor: 8.327

4.  Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1: ETS-1 regulates basal and and inducible p21WAF1/Cip: ETS-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements in the p21WAF/Cip1 promoter.

Authors:  Cuili Zhang; Mary M Kavurma; Angela Lai; Levon M Khachigian
Journal:  J Biol Chem       Date:  2003-05-09       Impact factor: 5.157

Review 5.  Targeting cell signaling and apoptotic pathways by luteolin: cardioprotective role in rat cardiomyocytes following ischemia/reperfusion.

Authors:  Tongda Xu; Dongye Li; Dehua Jiang
Journal:  Nutrients       Date:  2012-12-12       Impact factor: 5.717

6.  Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats.

Authors:  Dongdong Sun; Jie Huang; Zheng Zhang; Haokao Gao; Jiayi Li; Min Shen; Feng Cao; Haichang Wang
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

7.  ERK/PP1a/PLB/SERCA2a and JNK pathways are involved in luteolin-mediated protection of rat hearts and cardiomyocytes following ischemia/reperfusion.

Authors:  Xin Wu; Tongda Xu; Dongye Li; Shasha Zhu; Qiuping Chen; Wenjing Hu; Defeng Pan; Hong Zhu; Hong Sun
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

8.  Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction.

Authors:  Pin Lv; Mingxia Zhou; Jing He; Weiwei Meng; Xuehan Ma; Shuling Dong; Xianchun Meng; Xue Zhao; Xi Wang; Fucheng He
Journal:  Int J Mol Sci       Date:  2014-04-04       Impact factor: 5.923

Review 9.  Ischaemic conditioning and reperfusion injury.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Nat Rev Cardiol       Date:  2016-02-04       Impact factor: 32.419

Review 10.  Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis.

Authors:  B Martin; M Paesmans; T Berghmans; F Branle; L Ghisdal; C Mascaux; A-P Meert; E Steels; F Vallot; J-M Verdebout; J-J Lafitte; J-P Sculier
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640
View more
  2 in total

1.  At the crossroads from bench to bedside: luteolin is a promising pharmacological agent against myocardial ischemia reperfusion injury.

Authors:  Defeng Pan; Dongye Li
Journal:  Ann Transl Med       Date:  2016-12

Review 2.  Promising Therapeutic Candidate for Myocardial Ischemia/Reperfusion Injury: What Are the Possible Mechanisms and Roles of Phytochemicals?

Authors:  Cong Chen; Lin-Tong Yu; Bai-Ru Cheng; Jiang-Lin Xu; Yun Cai; Jia-Lin Jin; Ru-Li Feng; Long Xie; Xin-Yan Qu; Dong Li; Jing Liu; Yan Li; Xiao-Yun Cui; Jin-Jin Lu; Kun Zhou; Qian Lin; Jie Wan
Journal:  Front Cardiovasc Med       Date:  2022-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.